201 related articles for article (PubMed ID: 2464665)
1. [Alpha-fetoprotein and trisomy 21].
Guibaud S; Boisson C; Simplot A; Thoulon JM; Favier JP; Guibaud P; Robert JM
J Genet Hum; 1988 Aug; 36(4):347-51. PubMed ID: 2464665
[TBL] [Abstract][Full Text] [Related]
2. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
3. Biochemical markers of trisomy 21 in amniotic fluid.
Spencer K; Muller F; Aitken DA
Prenat Diagn; 1997 Jan; 17(1):31-7. PubMed ID: 9021826
[TBL] [Abstract][Full Text] [Related]
4. AFP and age screening for Down syndrome.
Wald N; Cuckle H
Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
[TBL] [Abstract][Full Text] [Related]
5. Amniotic fluid alpha-fetoprotein levels during midtrimester of trisomy pregnancies.
Hsu JJ; Hseih TT; Liou JD; Soong YK
J Formos Med Assoc; 1994 Jun; 93(6):492-6. PubMed ID: 7532053
[TBL] [Abstract][Full Text] [Related]
6. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs.
Ashwood ER; Cheng E; Luthy DA
Am J Med Genet; 1987 Mar; 26(3):531-9. PubMed ID: 2436476
[TBL] [Abstract][Full Text] [Related]
7. [The prenatal diagnosis of Down's syndrome based on the biochemical screening of maternal serum markers].
Arbuzova SB; Nikolenko MI; Khlevnaia LA; Fedotova OO; Solov'eva VD; Malova SA
Tsitol Genet; 1998; 32(1):66-71. PubMed ID: 9695254
[TBL] [Abstract][Full Text] [Related]
8. Second-trimester Down syndrome maternal serum screening in twin pregnancies: impact of chorionicity.
Muller F; Dreux S; Dupoizat H; Uzan S; Dubin MF; Oury JF; Dingeon B; Dommergues M
Prenat Diagn; 2003 Apr; 23(4):331-5. PubMed ID: 12673641
[TBL] [Abstract][Full Text] [Related]
9. Prenatal trisomy 21 screening using the Lens culinaris agglutinin-reactive alpha-fetoprotein ratio.
Yamamoto R; Minobe S; Ebina Y; Watari H; Kudo M; Henmi F; Satomura S; Fujimoto S; Minakami H; Sakuragi N
Congenit Anom (Kyoto); 2004 Jun; 44(2):87-92. PubMed ID: 15198721
[TBL] [Abstract][Full Text] [Related]
10. [AFP, uE3, beta-hCG levels applied for prenatal diagnosis of Down's syndrome].
Liao S; Wang Y; Ye G
Zhonghua Fu Chan Ke Za Zhi; 1997 Nov; 32(11):655-8. PubMed ID: 9639764
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Down's syndrome screening strategies in Asians combining serum free beta-hCG and alpha-fetoprotein with maternal age.
Hsu JJ; Hsieh TT; Soong YK; Spencer K
Prenat Diagn; 1997 Aug; 17(8):707-16. PubMed ID: 9267893
[TBL] [Abstract][Full Text] [Related]
12. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
13. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy].
Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A
Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094
[TBL] [Abstract][Full Text] [Related]
14. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
15. [Prenatal screening for Down's syndrome by measuring the AFP concentration in the maternal serum].
Veress L; Szabó M; Polgár K; Takács L; Papp Z
Orv Hetil; 1988 Jul; 129(31):1677. PubMed ID: 2476703
[No Abstract] [Full Text] [Related]
16. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
[TBL] [Abstract][Full Text] [Related]
17. Intrahepatic cholestasis of pregnancy has no effect on maternal serum second trimester alpha-fetoprotein and hCG.
Eloranta ML; Heinonen S; Kirkinen P
Acta Obstet Gynecol Scand; 2000 Jul; 79(7):548-52. PubMed ID: 10929953
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Down's syndrome screening population data sets by simulation: analyser-specific parameters may be superior to meta-analysis-derived parameters.
Reynolds TM; Vranken G; Van Nueten J; Aldis J
Int J Clin Pract; 2008 May; 62(5):735-43. PubMed ID: 17590221
[TBL] [Abstract][Full Text] [Related]
19. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
[TBL] [Abstract][Full Text] [Related]
20. Serum markers for Down's syndrome in relation to number of previous births and maternal age.
Wald NJ; Watt HC
Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
